NCT05285163

Brief Summary

Palliative care is of great importance because of poor quality of life and high mortality risk in advanced heart failure. This study was planned as a randomized controlled trial to determine the effect of palliative care training on symptom management, rehospitalization, and quality of life among patients with heart failure.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
84

participants targeted

Target at P50-P75 for not_applicable heart-failure

Timeline
Completed

Started Jan 2017

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2017

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2017

Completed
10 months until next milestone

Study Completion

Last participant's last visit for all outcomes

November 10, 2018

Completed
3.3 years until next milestone

First Submitted

Initial submission to the registry

March 4, 2022

Completed
13 days until next milestone

First Posted

Study publicly available on registry

March 17, 2022

Completed
Last Updated

March 17, 2022

Status Verified

March 1, 2022

Enrollment Period

12 months

First QC Date

March 4, 2022

Last Update Submit

March 14, 2022

Conditions

Keywords

heart failurepalliative carerehospitalizationsymptom burdenquality of life

Outcome Measures

Primary Outcomes (1)

  • Edmonton symptom assessment scale

    ESAS consists of 10 symptoms as tiredness, pain, feeling of well-being, nausea, depression, anxiety, lack of appetite, drowsiness, shortness of breath, and others. Each symptom is scored between 0 and 10. While Zero points indicate no symptoms, 10 points are severe of symptoms.

    six months

Secondary Outcomes (1)

  • LVD-36-left ventricular dysfunction questionnaire

    six months

Study Arms (2)

palliative care education

EXPERIMENTAL

The patients in the intervention group were presented palliative care training in addition to their usual care. The training period lasts at least 45 minutes. After the training, patients were given the book 'Palliative Care in Heart Failure'. In this training, patients were informed about heart failure and pharmacological and non-pharmacological methods for symptoms such as dyspnea, pain, constipation, depression, edema, tiredness, nausea. The patients were followed up by telephone at the first, third, and sixth months after discharge. The patient's symptoms and quality of life were re-evaluated in telephone follow-up. During the follow-up period, the patient's training related to symptoms was repeated. The patients were referred to the physician for the symptoms and problems which they experienced in the house.

Behavioral: palliative care educatiom

usual care

NO INTERVENTION

Firstly, the usual care provided to patients was described. It was determined that patients were not given regular and comprehensive training on heart failure, and no training was given on palliative care. Written educational material was not given to the patients. Patients were not followed up after discharge. Palliative care was not discussed with patients and their relatives. Also, they were not asked about their preferences. In usual care, Heart failure patients received medical treatment for their symptoms during hospitalization.

Interventions

The patients in the intervention group were presented palliative care training in addition to their usual care

palliative care education

Eligibility Criteria

Age18 Years - 86 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • year-old or over,
  • Class III and IV heart failure patients according to New York Heart Association (NYHA) classification,
  • Patients without any communication problem to prevent participation in the research \[loss of hearing, visual impairment, lack of understanding/speaking in Turkish\], can be contacted by telephone, are literate.
  • The patients who were diagnosed with heart failure at least six months ago accepted to participate voluntarily were also included in the study.

You may not qualify if:

  • Patients who wish to quit their study voluntarily during the study period and patients who died or worsened during the study period.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Marmara U.

Istanbul, Turkey (Türkiye)

Location

Marmara University

Istanbul, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Heart FailureDeath

Condition Hierarchy (Ancestors)

Heart DiseasesCardiovascular DiseasesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Gülşah Çamcı, PhD

    Marmara University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Masking Details
The patients were distributed with the minimization method of covariate-oriented randomization. According to NYHA (class III, IV), sex (male and female), and the number of hospitalizations (≤3 and ≥4) within one year, the patients were randomly appointed to the control and intervention groups. Thus, the patients in the intervention and control groups were distributed as homogeneous.
Purpose
PREVENTION
Intervention Model
PARALLEL
Model Details: The control group took usual care and the intervention group took both usual care and palliative care.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Prof

Study Record Dates

First Submitted

March 4, 2022

First Posted

March 17, 2022

Study Start

January 1, 2017

Primary Completion

December 31, 2017

Study Completion

November 10, 2018

Last Updated

March 17, 2022

Record last verified: 2022-03

Data Sharing

IPD Sharing
Will not share

After the article is published, the results of the study will be shared.

Locations